• 524 Citations
  • 12 h-Index
20042019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Dawit Aregawi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 524 Citations
  • 12 h-Index
  • 17 Article
  • 3 Chapter
  • 1 Comment/debate
  • 1 Letter

Management of low-grade glioma: A systematic review and meta-Analysis

Brown, T. J., Bota, D. A., Van Den Bent, M. J., Brown, P. D., Maher, E., Aregawi, D., Liau, L. M., Buckner, J. C., Weller, M., Berger, M. S. & Glantz, M., Jul 27 2019, In : Neuro-Oncology Practice. 6, 4, p. 249-258 10 p., npy034.

Research output: Contribution to journalArticle

  • 4 Scopus citations

    MLN8237 treatment in an orthoxenograft murine model for malignant peripheral nerve sheath tumors

    Payne, R., Mrowczynski, O. D., Slagle-Webb, B., Bourcier, A., Mau, C., Aregawi, D., Madhankumar, A. B., Lee, S. Y., Harbaugh, K., Connor, J. & Rizk, E. B., Feb 2019, In : Journal of neurosurgery. 130, 2, p. 465-475 11 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Spinal metastasis as complication of systemic cancers

    Davis, G., Lee, M., Aregawi, D., Shaffrey, M. E., Schiff, D. & Sherman, J. H., Sep 16 2017, Cancer Neurology in Clinical Practice: Neurological Complications of Cancer and its Treatment: Third Edition. Springer International Publishing, p. 113-125 13 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas

    Odia, Y., Kreisl, T. N., Aregawi, D., Innis, E. K. & Fine, H. A., Oct 1 2015, In : Journal of neuro-oncology. 125, 1, p. 191-195 5 p.

    Research output: Contribution to journalArticle

  • 20 Scopus citations

    Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: A multi-center study

    Pope, W. B., Qiao, X. J., Kim, H. J., Lai, A., Nghiemphu, P., Xue, X., Ellingson, B. M., Schiff, D., Aregawi, D., Cha, S., Puduvalli, V. K., Wu, J., Yung, W. K. A., Young, G. S., Vredenburgh, J., Barboriak, D., Abrey, L. E., Mikkelsen, T., Jain, R., Paleologos, N. A. & 5 others, Rn, P. L., Prados, M., Goldin, J., Wen, P. Y. & Cloughesy, T., Jul 1 2012, In : Journal of neuro-oncology. 108, 3, p. 491-498 8 p.

    Research output: Contribution to journalArticle

  • 109 Scopus citations